                         SEQUENCE LISTING

<110>  COMMISARIAT A L'ENERGIE ATOMIQUE (CEA)
 
<120>  HEMI-ANTICORPS A AUTO-ASSEMBLAGE

<130>  B08781A_AD/SL/CAL

<140>  PCT/FR2011/XXXXXX
<141>  2011-04-08

<150>  FR 10/01516
<151>  2010-04-09

<160>  11    

<170>  PatentIn version 3.3

<210>  1
<211>  15
<212>  DNA
<213>  Artificial

<220>
<223>  Polynuclotide (acide nuclique peptidique)

<400>  1
gtcccguccc cgcca                                                      15


<210>  2
<211>  8
<212>  PRT
<213>  Artificial

<220>
<223>  Peptide


<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa can be any naturally occuring amino acid

<400>  2

Leu Pro Xaa Thr Ala Ala Ala Ala 
1               5               


<210>  3
<211>  28
<212>  DNA
<213>  Artificial

<220>
<223>  Polynuclotide

<400>  3
tcaagtagct tcagaatctt ttcccccc                                        28


<210>  4
<211>  15
<212>  DNA
<213>  Artificial

<220>
<223>  Polynuclotide

<400>  4
ggctagctac aacga                                                      15


<210>  5
<211>  17
<212>  RNA
<213>  Artificial

<220>
<223>  antisens

<400>  5
gucccugucg ggcgcca                                                    17


<210>  6
<211>  18
<212>  RNA
<213>  Artificial

<220>
<223>  antisens


<220>
<221>  misc_feature
<222>  (1)..(19)
<223>  Squence complmentaire

<400>  6
cagggacaag cccgcggu                                                   18


<210>  7
<211>  5
<212>  PRT
<213>  Artificial

<220>
<223>  Peptide


<220>
<221>  misc_feature
<222>  (3)..(3)
<223>  Xaa can be any naturally occurring amino acid

<400>  7

Leu Pro Xaa Thr Gly 
1               5   


<210>  8
<211>  669
<212>  DNA
<213>  Artificial

<220>
<223>  (I-A) HS-LPGTG : partie variable de la chane lourde de 
       l'anticorps anti-HEL (Hen Egg Lysozyme)

<400>  8
caggtgcagc tgaaagaatc tggtccgggt ctggtggcgc cgtctcagtc tctgtctatt     60

acctgcaccg tgtctggttt ttctctgacc ggttatggtg tgaactgggt gcgtcagccg    120

ccgggtaaag gtctggaatg gctgggtatg atttggggtg atggtaacac cgattataac    180

tctgcgctga aatctcgtct gtctatttct aaagataact ctaaatctca ggtgtttctg    240

aaaatgaact ctctgcatac cgatgatacc gcgcgttatt attgcgcgcg tgaacgtgat    300

tatcgtctgg attattgggg tcagggtacc accctgaccg tgtcttctgc gtctaccacc    360

ccgccgtctg tgtttccgct ggcgccgggt tctgcggcgc agaccaactc tatggtgacc    420

ctgggttgcc tggtgaaagg ttattttccg gaaccggtga ccgtgacctg gaactctggt    480

tctctgtctt ctggtgtgca tacctttccg gcggtgctgc agtctgatct gtataccctg    540

tcttcttctg tgaccgtgcc gtcttctccg cgtccgtctg aaaccgtgac ctgcaacgtg    600

gcgcatccgg cgtcttctac caaagtggat aaaaaaattg tgccgcgtga ttgcctgccg    660

ggtaccggt                                                            669


<210>  9
<211>  657
<212>  DNA
<213>  Artificial

<220>
<223>  (I-B) LS-LPGTG : la partie variable de la chane lgre de 
       l'anticorps anti-HEL (Hen Egg Lysozyme)

<400>  9
gatattcaga tgacccagtc tccggcgtct ctgtctgcgt ctgtgggtga aaccgtgacc     60

attacctgcc gtgcgtctgg taacattcat aactatctgg cgtggtatca gcagaaacag    120

ggtaaatctc cgcagctgct ggtgtattat accaccaccc tggcggatgg tgtgccgtct    180

cgtttttctg gttctggttc tggtacccag tattctctga aaattaactc tctgcagccg    240

gaagattttg gttcttatta ttgccagcat ttttggtcta ccccgcgtac ctttggtggt    300

ggtaccaaac tggaaattaa acgtgcggat gcggcgccga ccgtgtctat ttttccgccg    360

tcttctgaac agctgacctc tggtggtgcg tctgtggtgt gctttctgaa caacttttat    420

ccgaaagata ttaacgtgaa atggaaaatt gatggttctg aacgtcagaa cggtgtgctg    480

aactcttgga ccgatcagga ttctaaagat tctacctatt ctatgtcttc taccctgacc    540

ctgaccaaag atgaatatga acgtcataac tcttatacct gcgaagcgac ccataaaacc    600

tctacctctc cgattgtgaa atcttttaac cgtaacgaat gcctgccggg taccggt       657


<210>  10
<211>  18
<212>  RNA
<213>  Artificial

<220>
<223>  ARN "Primer Binding Sequence" (ou PBS) du HIV-1

<400>  10
uggcgcccga acagggac                                                   18


<210>  11
<211>  63
<212>  DNA
<213>  Artificial

<220>
<223>  CCR5-WT (775-837)

<400>  11
agctctcatt ttccatacag tcagtatcaa ttctggaaga atttccagac attaaagata     60

gtc                                                                   63


